Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDK1 | Q15118 | 1/20 | 0.40 |
| ▸ | PDK2 | Q15119 | 1/20 | 0.40 |
| ▸ | PDK3 | Q15120 | 1/20 | 0.40 |
| ▸ | PDK4 | Q16654 | 1/20 | 0.40 |
| ▸ | AGTR2 | P50052 | 1/20 | 0.34 |
| ▸ | TSHR | P16473 | 1/20 | 0.33 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | HTR2C | P28335 | 1/20 | 0.33 |
| ▸ | FAAH | O00519 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL91189 | 0.80 | PDK1 (0.36) | PDK1PDK2PDK3PDK4AGTR2 | |
| SCHEMBL78783 | 0.76 | PDK1 (0.39) | PDK1PDK2PDK3PDK4AGTR2 | |
| SCHEMBL78407 | 0.76 | PDK1 (0.37) | PDK1PDK2PDK3PDK4HTR2C | |
| SCHEMBL78189 | 0.75 | PDK1 (0.38) | PDK1PDK2PDK3PDK4HTR2C | |
| SCHEMBL78185 | 0.74 | PDK1 (0.40) | PDK1PDK2PDK3PDK4TSHR | |
| SCHEMBL64675 | 0.74 | PDK1 (0.38) | PDK1PDK2PDK3PDK4 | |
| SCHEMBL78858 | 0.74 | PPARA (0.40) | PDK1PDK2PDK3PDK4TSHR | |
| SCHEMBL64676 | 0.73 | PDK1 (0.39) | PDK1PDK2PDK3PDK4TSHR | |
| SCHEMBL15341340 | 0.72 | PDK1 (0.45) | PDK1PDK2PDK3PDK4AGTR2 | |
| SCHEMBL25827425 | 0.72 | PDK1 (0.42) | PDK1PDK2PDK3PDK4HTR2C |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8129538-B1 | Renin inhibitors | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2012-03-06 | — | — | US | disclosed |